Clinical Trials
22 trialsNCT06279143 2026-05-26
dOCT-pBCC
Vejle Hospital
Completed
NCT03610022 2026-05-19
OPTIVISMO-1
University Hospital, Bordeaux
Phase 4 Completed
NCT00833417 2026-05-11
A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma
Genentech, Inc.
Phase 2 Completed
NCT00959647 2026-05-08
A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study
Genentech, Inc.
Phase 2 Completed
NCT06608238 2026-05-04
Phase 2 Study Evaluating the Safety and Efficacy of Microneedle-mediated Delivery of Doxorubicin (D-MNA) in Patients With Nodular Basal Cell Carcinoma.
SkinJect, Inc.
Phase 2 Completed
NCT06919809 2026-04-24
Effectiveness and Safety of X A-DERMâ„¢ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery
McGuire Institute
Phase NA Completed
NCT02667574 2026-04-22
VISMONEO
University Hospital, Lille
Phase 2 Completed
NCT05814900 2026-04-02
Investigation of Mohs Surgical Margins Using Two Photon Microscopy
University of Rochester
Phase NA Completed
NCT04480645 2026-03-24
CivaDerm(TM) Surface Therapy Pilot Study
CivaTech Oncology
Phase EARLY_PHASE1 Completed
NCT04066504 2026-03-18
NISSO
Sun Pharmaceutical Industries Limited
Completed
NCT07428941 2026-02-24
LegitHealth PH
AI Labs Group S.L
Completed
NCT03889912 2026-01-21
Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma
Regeneron Pharmaceuticals
Phase 1 Completed
NCT03509467 2025-12-19
Using MC1R Genotype to Impact Melanoma Risk Behavior
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT03534947 2025-12-16
SONIB
Melanoma Institute Australia
Phase 2 Completed
NCT04540588 2025-12-02
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
Alpha Tau Medical LTD.
Phase NA Completed
NCT01455363 2025-11-24
HPOB
Institut Curie
Phase NA Completed
NCT03836105 2025-10-15
CASE
Regeneron Pharmaceuticals
Completed
NCT06880848 2025-09-24
Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China
Jemincare
Phase 4 Completed
NCT06813833 2025-09-19
RNA-OCT-BCC
Bispebjerg Hospital
Completed
NCT07068568 2025-07-16
BCC-Sonidegib
Federico II University
Completed
NCT05188729 2025-06-18
Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma
Verrica Pharmaceuticals Inc.
Phase 2 Completed
NCT05138328 2025-06-15
Laser Treatment of Basal Cell Carcinoma Under Imaging Guidance
Henry Ford Health System
Phase NA Completed